Skip to main content
SpringerLink
Log in

Increased blood levels of venetoclax due to intake of crushed venetoclax tablets

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, Döhner H, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Hájek R, Porkka K, Illés Á, Lavie D, Lemoli RM, Yamamoto K, Yoon SS, Jang JH, Yeh SP, Turgut M, Hong WJ, Zhou Y, Potluri J, Pratz KW (2020) Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med 383:617–629. https://doi.org/10.1056/NEJMoa2012971

    Article  CAS  PubMed  Google Scholar 

  2. Yasu T, Gando Y, Nomura Y, Kosugi N, Kobayashi M (2022) Determination of venetoclax concentration in plasma using high-performance liquid chromatography. J Chromatogr Sci bmac027. https://doi.org/10.1093/chromsci/bmac027

  3. Guo Y, Liu B, Deng L, Qiao Y, Jian J (2020) The efficacy and adverse events of venetoclax in combination with hypomethylating agents treatment for patients with acute myeloid leukemia and myelodysplastic syndrome: a systematic review and meta-analysis. Hematology 25:414–423. https://doi.org/10.1080/16078454.2020.1843752

    Article  CAS  PubMed  Google Scholar 

  4. Salem AH, Agarwal SK, Dunbar M, Nuthalapati S, Chien D, Freise KJ, Wong SL (2016) Effect of low- and high-fat meals on the pharmacokinetics of venetoclax, a selective first-in-class BCL-2 inhibitor. J Clin Pharmacol 56:1355–1361. https://doi.org/10.1002/jcph.741

    Article  CAS  PubMed  Google Scholar 

  5. AbbVie Inc. (2021) VENCLEXTA® prescribing information. https://www.rxabbvie.com/pdf/venclexta.pdf. Accessed 2022 Apr 5

  6. Fields J, Go JT, Schulze KS (2015) Pill properties that cause dysphagia and treatment failure. Curr Ther Res Clin Exp 77:79–82. https://doi.org/10.1016/j.curtheres.2015.08.002

    Article  PubMed  PubMed Central  Google Scholar 

  7. Liu F, Ghaffur A, Bains J, Hamdy S (2016) Acceptability of oral solid medicines in older adults with and without dysphagia: a nested pilot validation questionnaire based observational study. Int J Pharm 512:374–381. https://doi.org/10.1016/j.ijpharm.2016.03.007

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan

    Maiko Anzai, Takeo Yasu & Mikio Shirota

  2. Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose , Tokyo, 204-8588, Japan

    Takeo Yasu & Yoshito Gando

  3. Department of Hematology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan

    Masayuki Kobayashi

Authors
  1. Maiko Anzai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takeo Yasu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshito Gando
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mikio Shirota
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masayuki Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takeo Yasu.

Ethics declarations

Ethics approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Consent to participate

Informed consent was obtained from the patient for publication.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anzai, M., Yasu, T., Gando, Y. et al. Increased blood levels of venetoclax due to intake of crushed venetoclax tablets. Ann Hematol 101, 2097–2098 (2022). https://doi.org/10.1007/s00277-022-04871-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-022-04871-2

Search

Navigation